Cargando…

Where next with therapy in advanced neuroblastoma?

Detalles Bibliográficos
Autor principal:	Pinkerton, C. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1990
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971292/ https://www.ncbi.nlm.nih.gov/pubmed/2183870

Ejemplares similares

Advances in digital CBT: where are we now, and where next?
por: Thew, Graham R., et al.
Publicado: (2022)

Where Next?
Publicado: (1897)

Beyond BRAF: where next for melanoma therapy?
por: Fedorenko, I V, et al.
Publicado: (2015)

Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
por: Philip, T., et al.
Publicado: (1993)

In Silico: Where Next?
por: Fairhall, Adrienne L.
Publicado: (2021)

Where Next for Genetics and Genomics?
por: Tyler-Smith, Chris, et al.
Publicado: (2015)

Malaria Vaccines: Where Next?
por: Holder, Anthony A.
Publicado: (2009)

Where Next for Microbiome Research?
por: Waldor, Matthew K., et al.
Publicado: (2015)

Where is genomics going next?
por: Cheifet, Barbara
Publicado: (2019)

Nutritional Psychiatry: Where to Next?
por: Jacka, Felice N.
Publicado: (2017)

Cancer Immunotherapy: Where Next?
por: Bodmer, Walter, et al.
Publicado: (2023)

Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?
por: Wagner, Lars M.
Publicado: (2015)

Genetics in schizophrenia: where are we and what next?
por: Tiwari, Arun K., et al.
Publicado: (2010)

BIRICODAR (VX-710; Incel™): an effective chemosensitizer in neuroblastoma
por: Yanagisawa, T, et al.
Publicado: (1999)

Stubborn Exercise Responders–Where to Next?
por: Bell, Leo R., et al.
Publicado: (2022)

Clinical results of proton beam therapy for advanced neuroblastoma
por: Oshiro, Yoshiko, et al.
Publicado: (2013)

Where Do Omics and Markers Go Next?
por: Sharp, Frank R.
Publicado: (2010)

NICE verdict on Temozolomide: where next?
por: Brada, M
Publicado: (2002)

E-learning in ophthalmology: Where next?
por: Walsh, Kieran
Publicado: (2014)

Malaria elimination in Zanzibar: where next?
por: Ali, Mohamed Haji, et al.
Publicado: (2023)

Cosmic microwave background, where next?
por: Licia Verde
Publicado: (2009)

Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
por: Cavallaro, Giacomo, et al.
Publicado: (2022)

Where Are We and Where to Next?—The Future of Perianal Crohn’s Disease Management
por: Anandabaskaran, Sulak, et al.
Publicado: (2023)

Outcome measures in psoriatic arthritis: Where next?
por: Hackett, Simon, et al.
Publicado: (2022)

Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). The European Neuroblastoma Study Group.
por: Pinkerton, C. R., et al.
Publicado: (1990)

The “addition” and “subtraction” of adjuvant chemotherapy for locally advanced colorectal cancer: where to go next?
por: Chen, Xin-Hua, et al.
Publicado: (2019)

Ovarian cancer: what’s new, where next?
por: A Spencer, John
Publicado: (2003)

New therapies for spinal muscular atrophy: where we stand and what is next
por: Antonaci, Laura, et al.
Publicado: (2023)

Where Will the Next Generation of Stroke Treatments Come From?
por: Howells, D. W., et al.
Publicado: (2010)

Mutual learning and reverse innovation–where next?
por: Crisp, Nigel
Publicado: (2014)

The case of referential gestural signaling: Where next?
por: Pika, Simone
Publicado: (2012)

Traditional Medicines in the World: Where to Go Next?
por: Pan, Si-Yuan, et al.
Publicado: (2014)

Where next for the reproducibility agenda in computational biology?
por: Lewis, Joanna, et al.
Publicado: (2016)

Tregs: Where We Are and What Comes Next?
por: Zhao, Hai, et al.
Publicado: (2017)

Immunotherapy failure in adrenocortical cancer: where next?
por: Cosentini, Deborah, et al.
Publicado: (2018)

Air pollution and children’s health: where next?
por: Whitehouse, Abigail, et al.
Publicado: (2021)

Analgesia for Sheep in Commercial Production: Where to Next?
por: Small, Alison, et al.
Publicado: (2021)

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
por: Mader, Reuven, et al.
Publicado: (2022)

Low Energy Trauma in Older Persons: Where to Next?
por: Chehade, Mellick, et al.
Publicado: (2015)

Endogenous cardiotonic steroids and cardiovascular disease, where to next?
por: Pavlovic, Davor
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v0b9ho75tg49hl6d2j8u75rber